Skip to main content
. 2012 Sep 29;16(4):338–340. doi: 10.5114/wo.2012.30064

Table 1.

Indication for monitoring of EBV-DNA according to type of transplant

Type of transplant Number of centers (%)
all alloSCT 32/64 (50.0%)
MUD-SCT 49/64 (76.5%)
T-depletion in vitro 40/64 (62.5%)
T-depletion in vivo 53/64 (82.8%)
family mismatched SCT 46/64 (71.9%)
cord blood SCT 48/64 (75.0%)
other 3 (SAA, EBV mismatch, autoimmune disease)

alloSCT – allogeneic stem cell transplantation; MUD – matched unrelated donor; SAA – severe aplastic anemia; EBV – Epstein-Barr virus